Lyon, France, May 12, 2020 – MaaT Pharma announced today the appointment of leading international…
nboutaouiMay 12, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
MaaT PharmaJanuary 31, 2020
Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
nboutaouiJanuary 31, 2020
Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaouiNovember 6, 2019
Jean-Marc Renard, MS, MBA, joins as Chief Business Officer Emmanuel Prestat, PhD, joins as Computational…
nboutaouiSeptember 10, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiAugust 13, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiJune 24, 2019
- First patents to cover the fundamental processes for accessing the human gut microbiome as…
nboutaouiMay 21, 2019
“Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute…
nboutaouiMay 21, 2019
